Literature DB >> 1586592

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.

J M Bartlett1, G J Rabiasz, W N Scott, S P Langdon, J F Smyth, W R Miller.   

Abstract

The pattern of TGF beta expression and in vitro response to TGF beta has been defined in three ovarian carcinoma cell lines (PEO1, PEO4 and PEO14). Marked differences in both mRNA expression and growth responses were detected between the cell lines. All expressed mRNA for TGF beta 3, PEO1 and PEO4 but not PEO14 expressed mRNA for TGF beta 1, whereas PEO14 but not PEO1 and PEO4 expressed TGF beta 2. Growth of PEO14 cells in culture was markedly inhibited by both TGF beta 1 and beta 2. PEO1 cells were inhibited by TGF beta 1, but not TGF beta 2 whilst growth of PEO4 cells were not affected by exposure to either of these peptides. These data indicate that several elements of potential autocrine loops involving TGF beta's are present within ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586592      PMCID: PMC1977402          DOI: 10.1038/bjc.1992.140

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells.

Authors:  R J Daly; P D Darbre
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

2.  Isolation and characterization of TGF-beta 2 and TGF-beta 5 from medium conditioned by Xenopus XTC cells.

Authors:  A B Roberts; F Rosa; N S Roche; J E Coligan; M Garfield; M L Rebbert; P Kondaiah; D Danielpour; J H Kehrl; S M Wahl
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

Review 3.  TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties.

Authors:  J Massagué; S Cheifetz; F T Boyd; J L Andres
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 4.  The cell biology of transforming growth factor beta.

Authors:  J A Barnard; R M Lyons; H L Moses
Journal:  Biochim Biophys Acta       Date:  1990-06-01

5.  Transforming growth factor-beta and ovarian carcinoma cells: regulation of proliferation and surface antigen expression.

Authors:  C Marth; T Lang; A Koza; I Mayer; G Daxenbichler
Journal:  Cancer Lett       Date:  1990-06-15       Impact factor: 8.679

Review 6.  Role of transforming growth factor-beta in bone remodeling.

Authors:  L F Bonewald; G R Mundy
Journal:  Clin Orthop Relat Res       Date:  1990-01       Impact factor: 4.176

7.  The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA.

Authors:  C Lucas; L N Bald; B M Fendly; M Mora-Worms; I S Figari; E J Patzer; M A Palladino
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

Review 8.  Transforming growth factor-beta and its actions on cellular growth and differentiation.

Authors:  M Nilsen-Hamilton
Journal:  Curr Top Dev Biol       Date:  1990       Impact factor: 4.897

9.  Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.

Authors:  B A Arrick; M Korc; R Derynck
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

Review 10.  Transforming growth factor-beta: multifunctional regulator of differentiation and development.

Authors:  A B Roberts; K C Flanders; U I Heine; S Jakowlew; P Kondaiah; S J Kim; M B Sporn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1990-03-12       Impact factor: 6.237

View more
  4 in total

1.  Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.

Authors:  M A Nash; R Lenzi; C L Edwards; J J Kavanagh; A P Kudelka; C F Verschraegen; C D Platsoucas; R S Freedman
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

2.  Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy.

Authors:  J MacCallum; J C Keen; J M Bartlett; A M Thompson; J M Dixon; W R Miller
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

3.  Expression of transforming growth factor beta mRNA isoforms in human breast cancer.

Authors:  J MacCallum; J M Bartlett; A M Thompson; J C Keen; J M Dixon; W R Miller
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

4.  The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.

Authors:  J M Bartlett; S P Langdon; B J Simpson; M Stewart; D Katsaros; P Sismondi; S Love; W N Scott; A R Williams; A M Lessells; K G Macleod; J F Smyth; W R Miller
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.